Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.

MLA

Sungjin Chung, et al. “Correction: Treatment Combining Aliskiren with Paricalcitol Is Effective against Progressive Renal Tubulointerstitial Fibrosis via Dual Blockade of Intrarenal Renin.” PLoS ONE, vol. 13, no. 5, Jan. 2018, p. e0196885. EBSCOhost, https://doi.org/10.1371/journal.pone.0196885.

APA

Sungjin Chung, Soojeong Kim, Minyoung Kim, Eun Sil Koh, Seok Joon Shin, Cheol Whee Park, Yoon Sik Chang, & Ho-Shik Kim. (2018). Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin. PLoS ONE, 13(5), e0196885. https://doi.org/10.1371/journal.pone.0196885

Chicago

Sungjin Chung, Soojeong Kim, Minyoung Kim, Eun Sil Koh, Seok Joon Shin, Cheol Whee Park, Yoon Sik Chang, and Ho-Shik Kim. 2018. “Correction: Treatment Combining Aliskiren with Paricalcitol Is Effective against Progressive Renal Tubulointerstitial Fibrosis via Dual Blockade of Intrarenal Renin.” PLoS ONE 13 (5): e0196885. doi:10.1371/journal.pone.0196885.